Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001104659-22-097694 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-06 | 2022-09-01+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $8.29 | +1,700 | 3.01M | +0.1% | +$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-02 | P | A | 1,200 | $8.37 | 3,010,609 | D | — | — | (F1) Includes 96,759 shares of restricted stock and 120,000 restricted stock units. |
| 2 | Common | Common Stock | 2022-09-01 | P | A | 500 | $8.11 | 3,009,409 | D | — | — | (F1) Includes 96,759 shares of restricted stock and 120,000 restricted stock units. |